The study involved 30 research groups across six countries — including Australia, the United States, Canada, Spain, Greece, and Austria — and analysed 7,525 cancer sample Instead of moving patient data, each
TNBC presents a unique challenge for conventional therapies because it lacks the specific proteins that are targeted by many traditional treatments for other forms of breast cancer Australian researchers are developing a
Significantly higher risks were found for certain types of cancer. New-onset T2D was associated with a 27 percent increased risk of bowel cancer in men and a 34 percent increased risk in
This reduction in risk is particularly significant, as colorectal cancer is one of the most common cancers worldwide, and lifestyle factors like diet are known to play a major role in its